Freeline Therapeutics Holdings (Freeline Therapeutics Holdings) Change In Other Working Capital : $-0.06 Mil (TTM As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Freeline Therapeutics Holdings Change In Other Working Capital?

Freeline Therapeutics Holdings's Change In Other Working Capital for the quarter that ended in Sep. 2023 was $0.06 Mil. It means Freeline Therapeutics Holdings's Other Working Capital increased by $0.06 Mil from Jun. 2023 to Sep. 2023 .

Freeline Therapeutics Holdings's Change In Other Working Capital for the fiscal year that ended in Dec. 2022 was $7.94 Mil. It means Freeline Therapeutics Holdings's Other Working Capital increased by $7.94 Mil from Dec. 2021 to Dec. 2022 .

Freeline Therapeutics Holdings Change In Other Working Capital Historical Data

The historical data trend for Freeline Therapeutics Holdings's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Freeline Therapeutics Holdings Change In Other Working Capital Chart

Freeline Therapeutics Holdings Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Other Working Capital

-0.16

0.10

0.01

7.94

Freeline Therapeutics Holdings Quarterly Data
	Dec18	Jun19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Change In Other Working Capital	Get a 7-Day Free Trial													1.32	-0.08	-0.09	0.05	0.06

Freeline Therapeutics Holdings Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.06 Mil.

Freeline Therapeutics Holdings Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Freeline Therapeutics Holdings's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Freeline Therapeutics Holdings (Freeline Therapeutics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Freeline Therapeutics Holdings PLC (NAS:FRLN) » Definitions » Change In Other Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

Gunnels Wood Road, Sycamore House, Stevenage, Hertfordshire, GBR, SG1 2BP

Website

https://www.freeline.life

Freeline Therapeutics Holdings PLC is a clinical-stage biotechnology company developing transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. Its lead product candidates are FLT180a for the treatment of hemophilia B, FLT190 for the treatment of Fabry disease and FLT201 for the treatment of Gaucher disease Type 1.